|
MARCKS expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.63413726994577E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.61257723524977E-12 |
| Normal-vs-Stage2 |
1.42840000050271E-07 |
| Normal-vs-Stage3 |
4.18739999996642E-06 |
| Normal-vs-Stage4 |
4.495800E-02 |
| Stage1-vs-Stage2 |
2.657400E-01 |
| Stage1-vs-Stage3 |
9.557600E-01 |
| Stage1-vs-Stage4 |
6.037200E-01 |
| Stage2-vs-Stage3 |
2.647800E-01 |
| Stage2-vs-Stage4 |
2.107200E-01 |
| Stage3-vs-Stage4 |
6.479800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.07913677993565E-13 |
| Normal-vs-AfricanAmerican |
8.1183004763119E-10 |
| Normal-vs-Asian |
6.032000E-02 |
| Caucasian-vs-AfricanAmerican |
4.655400E-01 |
| Caucasian-vs-Asian |
4.129400E-01 |
| AfricanAmerican-vs-Asian |
6.319200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.76205749780456E-14 |
| Normal-vs-Female |
2.78088663208109E-12 |
| Male-vs-Female |
3.402600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.63609999998182E-07 |
| Normal-vs-Extreme_Weight |
2.96940250166244E-11 |
| Normal-vs-Obese |
1.21720411527804E-11 |
| Normal-vs-Extreme_Obese |
7.568200E-02 |
| Normal_Weight-vs-Extreme_Weight |
8.384100E-02 |
| Normal_Weight-vs-Obese |
1.905700E-02 |
| Normal_Weight-vs-Extreme_Obese |
4.911200E-01 |
| Extreme_Weight-vs-Obese |
4.718200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.687020E-01 |
| Obese-vs-Extreme_Obese |
7.823700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.88349999725213E-08 |
| Normal-vs-Age(41-60Yrs) |
9.43689570931383E-15 |
| Normal-vs-Age(61-80Yrs) |
3.23263638080107E-12 |
| Normal-vs-Age(81-100Yrs) |
2.195500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.876200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.680200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.641600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.548360E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.978760E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.890600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
<1E-12 |
| Normal-VS-Type2 PRCC |
6.389300E-04 |
| Normal-VS-KIRP CIMP |
1.335550E-02 |
| Normal-VS-Unclassified PRCC |
3.13460000000987E-06 |
| Type1 PRCC-VS-Type2 PRCC |
9.44355704746158E-13 |
| Type1 PRCC-VS-KIRP CIMP |
2.767800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.862000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.017700E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.659600E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
6.680800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.32910000023068E-07 |
| Normal-vs-N1 |
6.14449999999378E-05 |
| Normal-vs-N2 |
2.273800E-02 |
| N0-vs-N1 |
3.526600E-01 |
| N0-vs-N2 |
6.691000E-01 |
| N1-vs-N2 |
4.247000E-01 |
|
|
